Tyngsborough, MA, United States of America

James Graham

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Insulet Corporation. Active years: 2024-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: James Graham. Retrieved from https://idiyas.com/inventor/james-graham-36ei2v0k

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 50.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2024-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of James Graham

Introduction

James Graham is an accomplished inventor based in Tyngsboro, MA (US). He has made significant contributions to the field of medical technology, particularly in insulin delivery systems. His innovative approach has led to the development of a patent that enhances the management of insulin delivery for users.

Latest Patents

James Graham holds a patent for "Open-loop insulin delivery basal parameters based on insulin delivery records." This patent discloses techniques and a device that determine the total amount of insulin delivered to a user over a predetermined time period. The total amount of insulin includes both basal and bolus dosages. The invention calculates the proportion of total insulin attributed to basal dosages and generates instructions to modify the basal dosage to maintain optimal delivery.

Career Highlights

James Graham is currently associated with Insulet Corporation, a company known for its innovative solutions in diabetes management. His work focuses on improving insulin delivery systems, which are crucial for individuals managing diabetes. With a patent portfolio that includes 1 patent, he continues to push the boundaries of medical technology.

Collaborations

James has collaborated with notable colleagues such as Joon Bok Lee and Jason B O'Connor. Their combined expertise contributes to the advancement of insulin delivery technologies and enhances the overall effectiveness of diabetes management solutions.

Conclusion

James Graham's contributions to insulin delivery technology exemplify the impact of innovation in healthcare. His patent and work at Insulet Corporation highlight the importance of advancements in medical devices for improving patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…